SCHEMBL22792825

SCHEMBL22792825

Cc1nc2c(cc1C(C)(C)C)OCN2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22792901 0.85 — —
SCHEMBL22792730 0.74 — —
SCHEMBL22792917 0.73 — —
SCHEMBL22792664 0.71 ALDH1A1 (0.31) —
SCHEMBL17430662 0.66 GRM5 (0.36) —
SCHEMBL22792869 0.63 — —
SCHEMBL20153298 0.63 ALDH1A1 (0.42) —
SCHEMBL22792864 0.63 ADRA2A (0.33) —
SCHEMBL13424834 0.61 ALDH1A1 (0.40) —
SCHEMBL22792650 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10988466-B2 Heterocyclic derivatives useful as SHP2 inhibitors JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2021-04-27 — — US disclosed
US-20200392128-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2020-12-17 — — US disclosed
Send feedback